By Kelly Stewart
How can you get drugs to market faster without sacrificing quality, all while saving time and money? This is the multi-billion dollar question pharma companies around are struggling to answer and Parma 4.0 may be the solution.
Pharma 4.0 refers to the convergence of people, systems, and data within one singular network. This term was originally coined by the International Society for Pharmaceutical Engineers (ISPE), and it represents a new era of digital transformation powered by innovative, advanced technologies such as artificial intelligence (AI) and machine learning.
These cutting-edge technologies instantly bridge knowledge and information gaps, providing life science professionals with relevant insights, available on demand. As a result, Pharma 4.0 connected systems can make better predictions, trigger automatic processes, and optimize the entire drug development and manufacturing workflow.
In this article, we delve into this industry buzzword and explore its role in the future of pharma manufacturing. We outline clear steps you can take to realize its potential in your organization.